Analyst Ratings for Boston Scientific (BSX) [Neutrals]
BSX Rating Summary
BSX Price Target Summary
- Highest: $81.00 (Canaccord Genuity)
- Lowest: $60.00 (Stifel)
- Average: $70.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$70.67 (+4.9%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$70.67 (+4.9%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/1/2021 | Deutsche Bank » Updated 4/29/2021 |
Pito Chickering | New Coverage | Hold (N/A) |
45.00 (39.00) |
35.44 (67.36) |
90.07% | Details |
| 7/30/2020 | Piper Sandler » Updated 7/6/2023 |
Matt O'Brien | Downgrade | Neutral (Overweight) |
62.00 (58.00) |
38.27 (67.36) |
76.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
